[1]聂永新,占海港,杨盆英.舍曲林联合拉莫三嗪治疗精神分裂症后抑郁的疗效观察[J].医学信息,2019,32(06):161-163.[doi:10.3969/j.issn.1006-1959.2019.06.052]
 NIE Yong-xin,ZHAN Hai-Gang,YANG Pen-ying.Therapeutic Effect of Sertraline Combined with Lamotrigine on Post-schizophrenia Depression[J].Journal of Medical Information,2019,32(06):161-163.[doi:10.3969/j.issn.1006-1959.2019.06.052]
点击复制

舍曲林联合拉莫三嗪治疗精神分裂症后抑郁的疗效观察()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年06期
页码:
161-163
栏目:
药物与临床
出版日期:
2019-03-15

文章信息/Info

Title:
Therapeutic Effect of Sertraline Combined with Lamotrigine on Post-schizophrenia Depression
文章编号:
1006-1959(2019)06-0161-03
作者:
聂永新占海港杨盆英
(江西省鄱阳县鄱阳康乐精神病医院精神科,江西 鄱阳 333100)
Author(s):
NIE Yong-xinZHAN Hai-GangYANG Pen-ying
(Department of Psychiatry,Poyang Kang Le Psychiatric Hospital,Poyang 333100,Jiangxi,China)
关键词:
拉莫三嗪舍曲林精神分裂症抑郁
Keywords:
LamotrigineSertralineSchizophreniaDepression
分类号:
R749.3
DOI:
10.3969/j.issn.1006-1959.2019.06.052
文献标志码:
A
摘要:
目的 探讨拉莫三嗪治疗精神分裂症后抑郁的临床疗效、抑郁评分的变化及安全性。方法 选取2017年8月~2018年11月在我院住院的精神分裂症患者80例,随机分为对照组和观察组,每组40例。对照组给予抗精神病药物治疗的同时联用舍曲林治疗,观察组在对照组的基础上加用拉莫三嗪治疗,疗程8周。采用汉密尔顿抑郁量表(HAMD17)、临床疗效总评量表(CGI)、治疗中出现的副反应量表(TESS)分别在治疗前、治疗后第1、2、4、8周对两组的疗效、不良反应发生率进行统计分析。结果 两组治疗1、2、4、8周后的HAMD、CGI评分均低于治疗前,且观察组低于对照组,差异有统计学意义(P<0.05)。治疗8周后,观察组痊愈率为95.00%(38/40),高于对照组的80.00%(32/40),差异有统计学意义(P<0.05)。两组患者治疗1、2、4、8周时的TESS评分比较,差异无统计学意义(P>0.05)。观察组不良反应发生率为27.50%(11/40),对照组为20.00%(8/40),两组比较,差异无统计学意义(P>0.05)。结论 拉莫三嗪与舍曲林联合治疗比单用舍曲林治疗精神分裂症后抑郁疗效更好,起效更快,未增加不良反应,有较好的应用价值。
Abstract:
Objective To investigate the clinical efficacy, depression score and safety of lamotrigine in the treatment of post-schizophrenia depression. Methods 80 patients with schizophrenia admitted to our hospital from August 2017 to November 2018 were randomly divided into the control group and the observation group, with 40 cases in each group. The control group was treated with antipsychotic drugs and treated with sertraline. The observation group was treated with lamotrigine on the basis of the control group for 8 weeks. The Hamilton Depression Scale (HAMD17), the Clinical Outcome Scale (CGI), and the Side Effects Scale (TESS) during treatment were used to treat the two groups before treatment and at 1, 2, 4, and 8 weeks after treatment. Statistical analysis of the incidence of adverse reactions. Results The HAMD and CGI scores of the two groups after treatment for 1, 2, 4 and 8 weeks were lower than those before treatment, and the observation group was lower than the control group, the difference was statistically significant (P<0.05). After 8 weeks of treatment, the cure rate of the observation group was 95.00% (38/40), which was higher than that of the control group 80.00% (32/40). The difference was statistically significant (P<0.05).There was no significant difference in the TESS scores between the two groups at 1, 2, 4, and 8 weeks (P>0.05). The incidence of adverse reactions was 27.50% (11/40) in the observation group and 20.00% (8/40) in the control group. There was no significant difference between the two groups (P>0.05). Conclusion The combination of lamotrigine and sertraline is more effective than sertraline alone in the treatment of post-schizophrenia depression. It has a faster onset, no increase in adverse reactions, and has good application value.

参考文献/References:

[1]刘海玲.左乙拉西坦联合拉莫三嗪治疗难治性颞叶癫痫的效果观察[J].中国实用医刊,2018,45(20):121-123. [2]李植祥.拉莫三嗪治疗双相情感障碍抑郁发作对照研究[J].现代中西医结合杂志,2014,23(6):618-619. [3]黄华威,丘永明,曾伦.拉莫三嗪治疗双相情感障碍急性抑郁发作的效果[J].白求恩医学杂志,2018,16(4):365-366. [4]赵靖平.精神病学新进展[M].北京:人民卫生出版社,2009:35-41. [5]陆林.沈渔邨精神病学[M].北京:人民卫生出版社,2018:300-334,400-402. [6]陈松,张江涛.舒肝解郁胶囊联合重复经颅磁刺激治疗精神分裂症后抑郁疗效观察[J].浙江中西医结合杂志,2018,28(1):30-32. [7]王静,杜红兴,朱红颖.喹硫平联合舍曲林治疗首发精神分裂症患者抑郁症状的临床效果[J].中国急救医学,2015,35(2):107-108. [8]Mlinar B,Montalbano A,Baccini G,et al.Nonexocytotic serotonin release tonically suppresses serotonergic neuron activity[J].The Journal of General Physiology,2015,145(3):225-251. [9]夏晖.5-HT1A部分激动和5-HT重摄取抑制双靶标抗抑郁新药YL-0919的行为学评价及神经可塑性机制研究[D].中国人民解放军军事医学科学院,2014. [10]林娜,柳洋,祁晖,等.拉莫三嗪抗抑郁作用及其机制研究[J].济宁医学院学报,2018,41(3):163-166,170.

相似文献/References:

[1]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状 疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
 CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Journal of Medical Information,2018,31(06):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[2]胡青婷.丙戊酸钠联合拉莫三嗪治疗脑卒中继发性癫痫的效果观察[J].医学信息,2018,31(11):127.[doi:10.3969/j.issn.1006-1959.2018.11.040]
 HU Qing-ting.Effect of Sodium Valproate Combined with Lamotrigine in the Treatment of Secondary Post-stroke Epilepsy[J].Journal of Medical Information,2018,31(06):127.[doi:10.3969/j.issn.1006-1959.2018.11.040]
[3]范银燕.舍曲林联合丙戊酸钠对癫痫伴精神障碍的疗效评价[J].医学信息,2018,31(12):134.[doi:10.3969/j.issn.1006-1959.2018.12.041]
 FAN Yin-yan.Efficacy of Sertraline Combined with Sodium Valproate in the Treatment of Epilepsy with Mental Disorders[J].Journal of Medical Information,2018,31(06):134.[doi:10.3969/j.issn.1006-1959.2018.12.041]
[4]田 野,徐桂娟,宋 震,等.沙盘游戏治疗对轻中度抑郁障碍患者 个人和社会功能的影响分析[J].医学信息,2018,31(17):86.[doi:10.3969/j.issn.1006-1959.2018.17.026]
 TIAN Ye,XU Gui-juan,SONG Zhen,et al.Analysis of the Influence of Sand Table Game Therapy on Personal and Social Function of Patients with Mild to Moderate Depressive Disorder[J].Journal of Medical Information,2018,31(06):86.[doi:10.3969/j.issn.1006-1959.2018.17.026]
[5]冯友亮.舍曲林联合坦索罗辛治疗慢性前列腺炎顽固性尿道疼痛的近期疗效[J].医学信息,2019,32(24):81.[doi:10.3969/j.issn.1006-1959.2019.24.026]
 FENG You-liang.Short-term Efficacy of Sertraline Combined with Tamsulosin in the Treatment of Refractory Urethral Pain in Chronic Prostatitis[J].Journal of Medical Information,2019,32(06):81.[doi:10.3969/j.issn.1006-1959.2019.24.026]
[6]叶 欢,周 华,沈 蓉,等.早期应用不同剂量舍曲林干预脑梗死患者卒中后抑郁效果观察[J].医学信息,2020,33(06):141.[doi:10.3969/j.issn.1006-1959.2020.06.045]
 YE Huan,ZHOU Hua,SHEN Rong,et al.Effect of Early Application of Different Doses of Sertraline on Post-stroke Depression in Patients with Cerebral Infarction[J].Journal of Medical Information,2020,33(06):141.[doi:10.3969/j.issn.1006-1959.2020.06.045]
[7]张培文.舍曲林治疗合并焦虑抑郁的慢性阻塞性肺疾病患者的效果研究[J].医学信息,2021,34(14):148.[doi:10.3969/j.issn.1006-1959.2021.14.041]
 ZHANG Pei-wen.Effect of Sertraline in the Treatment of Chronic Obstructive Pulmonary Disease Patients with Anxiety and Depression[J].Journal of Medical Information,2021,34(06):148.[doi:10.3969/j.issn.1006-1959.2021.14.041]

更新日期/Last Update: 2019-03-15